Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Blood Transfusion01:15

Blood Transfusion

562
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
562
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Blood Typing01:10

Blood Typing

1.2K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.3K
Overview
68.3K
Rh Blood Group01:19

Rh Blood Group

1.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving sustainable anti-D immunoprophylaxis in Europe.

Vox sanguinis·2026
Same author

Cost-effectiveness of cEK-preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting.

Vox sanguinis·2026
Same author

Routine use of a spike-in DNA in-process control for foetal RHD genotyping: Testing the real-world effectiveness of this 'canary'.

Vox sanguinis·2026
Same author

Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study.

Transfusion·2025
Same author

Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

JCO precision oncology·2025
Same author

Longitudinal plasma proteomics in romiplostim-treated patients with immune thrombocytopenia.

British journal of haematology·2025

Related Experiment Video

Updated: Jul 4, 2025

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.1K

Extensive red blood cell matching considering patient alloimmunization risk.

Merel L Wemelsfelder1,2, Ronald H G van de Weem1, Jessie S Luken3,4

  • 1Donor Medicine Research Department, Sanquin Research, Amsterdam, the Netherlands.

Vox Sanguinis
|January 29, 2024
PubMed
Summary

This study improved red blood cell (RBC) transfusion matching by prioritizing patient groups and considering scheduled transfusions. The updated model reduces alloimmunization risks, mismatches, and shortages, enhancing patient safety.

Keywords:
RBC matchingextensive antigen typinglinear optimizationsupply chain

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.1K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.3K

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Health Informatics

Background:

  • Red blood cell (RBC) transfusions carry a risk of alloantibody development.
  • Extended antigen matching beyond ABO-D is recommended for high-risk patients.
  • Current allocation models may not fully account for patient-specific risks and clinical consequences.

Purpose of the Study:

  • To refine the MINimize Relative Alloimmunization Risks (MINRAR) model for RBC unit selection.
  • To incorporate patient group preferences and clinical mismatch consequences into allocation.
  • To evaluate the impact of strategic blood distribution informed by scheduled transfusions.

Main Methods:

  • Redefined the MINRAR model using linear optimization.
  • Included antigen immunogenicity and clinical mismatch impact.
  • Evaluated the model with historical data from two Dutch hospitals, assessing shortages and antigen mismatches.

Main Results:

  • The updated model reduced expected alloimmunization consequences by shifting mismatches.
  • Simultaneous multi-hospital matching with scheduled demand decreased mismatches by 30%.
  • Shortages were reduced by 92% through collaborative, strategic blood distribution.

Conclusions:

  • Incorporating patient group preferences effectively reduces alloimmunization consequences.
  • Multi-hospital collaboration and information sharing significantly decrease RBC mismatches and shortages.
  • The refined strategy enhances patient health outcomes in transfusion medicine.